Literature DB >> 17952481

Hydroxychloroquine-induced DRESS syndrome.

Alessandro Volpe1, Antonio Marchetta, Paola Caramaschi, Domenico Biasi, Lisa Maria Bambara, Guido Arcaro.   

Abstract

The authors describe the first case of drug rash with eosinophilia and systemic symptoms syndrome caused by hydroxychloroquine treatment in a male patient affected by seronegative arthritis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17952481     DOI: 10.1007/s10067-007-0772-1

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   3.650


  7 in total

1.  Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?

Authors:  S H Kardaun; A Sidoroff; L Valeyrie-Allanore; S Halevy; B B Davidovici; M Mockenhaupt; J C Roujeau
Journal:  Br J Dermatol       Date:  2007-03       Impact factor: 9.302

2.  The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations.

Authors:  T Shiohara; M Iijima; Z Ikezawa; K Hashimoto
Journal:  Br J Dermatol       Date:  2007-03-23       Impact factor: 9.302

3.  Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?

Authors:  H Peyrière; O Dereure; H Breton; P Demoly; M Cociglio; J-P Blayac; D Hillaire-Buys
Journal:  Br J Dermatol       Date:  2006-08       Impact factor: 9.302

4.  Delayed hypersensitivity to hydroxychloroquine manifested by two different types of cutaneous eruptions in the same patient.

Authors:  P Rojas Pérez-Ezquerra; M de Barrio Fernández; F J de Castro Martínez; F J Ruiz Hornillos; A Prieto García
Journal:  Allergol Immunopathol (Madr)       Date:  2006 Jul-Aug       Impact factor: 1.667

Review 5.  Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS).

Authors:  H Bocquet; M Bagot; J C Roujeau
Journal:  Semin Cutan Med Surg       Date:  1996-12

Review 6.  Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses.

Authors:  Tetsuo Shiohara; Miyuki Inaoka; Yoko Kano
Journal:  Allergol Int       Date:  2006-03       Impact factor: 5.836

Review 7.  The immunological and clinical spectrum of delayed drug-induced exanthems.

Authors:  Marianne Lerch; Werner J Pichler
Journal:  Curr Opin Allergy Clin Immunol       Date:  2004-10
  7 in total
  11 in total

Review 1.  Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection.

Authors:  David N Juurlink
Journal:  CMAJ       Date:  2020-04-08       Impact factor: 8.262

Review 2.  Safety of Short-Term Treatments with Oral Chloroquine and Hydroxychloroquine in Patients with and without COVID-19: A Systematic Review.

Authors:  Sergio Marin; Alba Martin Val; Maite Bosch Peligero; Cristina Rodríguez-Bernuz; Ariadna Pérez-Ricart; Laia Vilaró Jaques; Roger Paredes; Josep Roca; Carles Quiñones
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-21

Review 3.  Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome and the Rheumatologist.

Authors:  Marwan H Adwan
Journal:  Curr Rheumatol Rep       Date:  2017-01       Impact factor: 4.686

4.  Stevens Johnson syndrome after carbamazepine and SJS/TEN overlap syndrome after amoxicillin: case reports and a review.

Authors:  Krystyna Romańska-Gocka; Jacek Gocki; Waldemar Placek; Barbara Zegarska; Paweł Krause
Journal:  Arch Med Sci       Date:  2010-03-09       Impact factor: 3.318

Review 5.  Practical Management of Respiratory Comorbidities in Patients with Rheumatoid Arthritis.

Authors:  James Bluett; Meghna Jani; Deborah P M Symmons
Journal:  Rheumatol Ther       Date:  2017-08-14

6.  Hydroxychloroquine-induced Stevens-Johnson syndrome in COVID-19: a rare case report.

Authors:  Lotfollah Davoodi; Hamed Jafarpour; Armaghan Kazeminejad; Eissa Soleymani; Zahra Akbari; Alireza Razavi
Journal:  Oxf Med Case Reports       Date:  2020-06-25

7.  Drug Rash with Eosinophilia and Systemic Symptoms Syndrome Due to Anti-TB Medication.

Authors:  Dharmesh H Kaswala
Journal:  J Family Med Prim Care       Date:  2013-01

8.  Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID-19.

Authors:  A Herman; M Matthews; M Mairlot; L Nobile; L Fameree; L-M Jacquet; M Baeck
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-07-31       Impact factor: 6.166

9.  First case of DRESS syndrome caused by hydroxychloroquine with a positive patch test.

Authors:  Araceli Castro Jiménez; Nuria Navarrete Navarrete; Alejandro R Gratacós Gómez; Fernando Florido López; Rosa García Rodríguez; Elisa Gómez Torrijos
Journal:  Contact Dermatitis       Date:  2020-07-28       Impact factor: 6.600

10.  Diagnosis and management of the drug hypersensitivity reactions in Coronavirus disease 19: An EAACI Position Paper.

Authors:  Aslı Gelincik; Knut Brockow; Gülfem E Çelik; Inmaculada Doña; Cristobalina Mayorga; Antonino Romano; Özge Soyer; Marina Atanaskovic-Markovic; Annick Barbaud; Maria Jose Torres
Journal:  Allergy       Date:  2020-07-01       Impact factor: 14.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.